Skip to main content
OpenTrials

Clinical trial condition

Mpox, Monkeypox

Explore clinical trials studying Mpox, Monkeypox. Study availability and eligibility vary by location and protocol.

58 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Mpox, Monkeypox trial results

Completed

Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine

NCT05512949

Conditions
Animal Diseases, DNA Virus Infections, Infections, +6 more
Locations
  • University of California, San Diego (UCSD) - Antiviral Research Center (AVRC) San Diego, California, United States
  • George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
  • The Hope Clinic of Emory University Decatur, Georgia, United States
  • NIH Clinical Research Center, Investigational Drug Management and Research Section Bethesda, Maryland, United States
View Trial Details
Completed

A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines

NCT05988203

Conditions
Animal Diseases, DNA Virus Infections, Infections, +6 more
Locations
  • California Research Foundation San Diego, California, United States
  • Alliance for Multispecialty Research, LLC Kansas City, Missouri, United States
  • Alliance for Multispecialty Research, LLC Knoxville, Tennessee, United States
  • University of Washington Virology Research Clinic Seattle, Washington, United States
View Trial Details
Completed

A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox

NCT05740982

Conditions
Animal Diseases, DNA Virus Infections, Infections, +6 more
Locations
  • Children's of Alabama Child Health Research Unit (CHRU) Birmingham, Alabama, United States
  • George Washington University Medical Faculty Associates Washington D.C., District of Columbia, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Maryland, School of Medicine, Center for Vaccine Development and Global Health Baltimore, Maryland, United States
View all 18 locations
View Trial Details
Completed

Tecovirimat for Treatment of Monkeypox Virus

NCT05559099

Conditions
Animal Diseases, DNA Virus Infections, Infections, +6 more
Locations
  • L'Hôpital Général de Référence de Kole Kole, Democratic Republic of the Congo
  • L'Hôpital Général de Référence de Tunda Tunda, Democratic Republic of the Congo
View Trial Details
Completed

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV

NCT05965427

Conditions
Animal Diseases, Blood-Borne Infections, Communicable Diseases, +19 more
Locations
  • Hôpital Bichat Claude Bernard Paris, France
  • Hôpital Pitié-Salpêtrière Paris, France
  • Euroguidelines Warsaw, Poland
  • Hospital Clinic de Barcelona Barcelona, Spain
View Trial Details
Completed

A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

NCT05995275

Conditions
Animal Diseases, DNA Virus Infections, Infections, +7 more
Locations
  • Bradford Teaching Hospitals NHS Foundation Trust Bradford, United Kingdom
  • University Hospitals Bristol and Weston NHS Foundation Trust Bristol, United Kingdom
  • Lakeside Healthcare Research Corby, United Kingdom
  • University Hospitals of Leicester Leicester, United Kingdom
View Trial Details

Related conditions